General Partner Rogier Rooswinkel was a contributing author to the article "Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment" published in Nature Communications.
Click here to access the article on the Nature Communications website.